Join the Endometriosis group to help and get support from people like you.
Endometriosis News
Endometriosis Linked to Higher Heart Risks for Women
MONDAY, Sept 2, 2024 – Endometriosis can be a painful, debilitating condition for many women, but new research suggests even more serious consequences: higher odds for heart attacks or strokes....
Risk for Ovarian Cancer Increased for Women With Endometriosis
THURSDAY, July 18, 2024 – Women with endometriosis have an increased risk of ovarian cancer, with the highest risk seen for women with deep infiltrating endometriosis and/or ovarian endometriomas,...
Endometriosis Linked to Four-fold Higher Odds for Ovarian Cancer
THURSDAY, July 18, 2024 – Women who struggle with endometriosis may be vulnerable to another health danger: New research shows they are about four times more likely to develop ovarian cancer than...
Recommendations Developed to Improve Endometriosis Diagnosis
MONDAY, April 22, 2024 – In a Society of Radiologists in Ultrasound expert consensus statement published online April 9 in Radiology, recommendations are presented for the diagnosis and management...
How to Deal With Endometriosis Pain
SATURDAY, March 9, 2024 – Endometriosis causes crippling pain in women, with some spending up to a month of every year debilitated by it. “We’re talking about pain that’s beyond ‘I took two ibuprof...
Endometriosis Can Complicate a Hysterectomy
TUESDAY, Oct. 31, 2023 – Patients living with endometriosis are more likely to have complications during and after a hysterectomy, new research indicates. Knowing that, surgeons should be prepared...
Endometriosis Tied to Higher Rates of Hysterectomy Complications
TUESDAY, Oct. 31, 2023 – Endometriosis is associated with higher rates of postoperative complications for hysterectomy involving benign conditions, according to a study published online Sept. 12 in...
Myovant Sciences and Pfizer Receive U.S. FDA Approval of Myfembree, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
BASEL, Switzerland and NEW YORK, [August 05, 2022] (GLOBE NEWSWIRE) – Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Orilissa (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
NORTH CHICAGO, Ill., July 24, 2018 /PRNewswire/ – AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), announced...
Further information
Related drug support groups
Provera, Sprintec, Lupron Depot, progesterone, medroxyprogesterone